Analyze The Worldwide Markets For Artificial Organs In US$ Million

Research and Markets (http://www.researchandmarkets.com/reports/c49913) has announced the addition of “Artificial Organs – Global Strategic Business Report” to their offering.

This report analyzes the worldwide markets for Artificial Organs in US$ Million. The major product segments analyzed are Artificial Heart, Artificial Kidneys, Artificial Liver, Artificial Pancreas, and Artificial Lungs. Annual forecasts are provided for the period of 2000 through 2010. The report profiles 68 companies including many key and niche players worldwide such as:

-Abbott Laboratories

-Abiomed Inc.

-Aksys Ltd.

-Algenix Inc.

-Arbios Systems Inc.

-Arrow International, Inc.

-Asahi Kasei Medical Co., Ltd.

-Baxter International, Inc.

-Bayer AG

-Fresenius Medical Care AG & Co. KGaA

-Fresenius Medical Care Holdings

-Fresenius Kawasumi

-Fresenius Medical Care Japan KK

-Renal Care Group

-Gambro AB

-Gish Biomedical Inc.

-HepaLife Technologies Inc.

-Jarvik Heart Inc.

-Kawasumi Laboratories

-MC3 Inc.

-Medtronic Inc.

-MicroMed Technology Inc.

-Minntech Renal Systems

-Nikkiso Co Ltd

-Nipro Corporation

-RenalPlant Corporation

-Roche Group

-SynCardia Systems Inc.

-Terumo Corporation

-Thoratec Corporation

-Toray Medical Co., Ltd.

-Ventracor Limited

-Vital Therapies Inc.

-World Heart Corporation

-Xenogenics Corporation.

Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.

For information on site licence pricing please click on “Enquire before buying”

Topics Covered:

-Market Trends and Issues

-Higher Development Costs and Lengthy Regulatory Process

-Competitive Scenario

-Product Overview

-Introduction to Biomaterials

-Organ Transplantation

-Regulatory Environment

-Product Developments/Introductions

-Recent Industry Activity

-Focus on Select Global Players

-Global Market Perspective

For more information, visit http://www.researchandmarkets.com/reports/c49913